The p38 and JNK Pathways Cooperate to trans-Activate Vitamin D Receptor via c-Jun/AP-1 and Sensitize Human Breast Cancer Cells to Vitamin D3-induced Growth Inhibition
Open Access
- 1 July 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (29) , 25884-25892
- https://doi.org/10.1074/jbc.m203039200
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Mammalian MAP kinase signalling cascadesNature, 2001
- p38 MAP kinases: beyond the stress responseTrends in Biochemical Sciences, 2000
- The p38 signal transduction pathway Activation and functionCellular Signalling, 1999
- From receptors to stress-activated MAP kinasesOncogene, 1999
- Resistance of HBL100 human breast epithelial cells to vitamin D actionCarcinogenesis: Integrative Cancer Research, 1999
- Current Understanding of the Molecular Actions of Vitamin DPhysiological Reviews, 1998
- Vitamin D receptor stable transfection restores the susceptibility to 1,25-dihydroxyvitamin D3cytotoxicity in a rat glioma resistant cloneJournal of Neuroscience Research, 1998
- 1,25-Dihydroxyvitamin D3Induction of Nerve Growth Factor in L929 Mouse Fibroblasts: Effect of Vitamin D Receptor Regulation and Potency of Vitamin D3Analogs1Endocrinology, 1997
- A protein kinase involved in the regulation of inflammatory cytokine biosynthesisNature, 1994
- A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian CellsScience, 1994